Animal ''Avatars'' and co-clinical trials represent an emerging concept for 25 implementing schemes of personalized medicine in oncology. In a co-clinical 26 trial, the cancer cells of the patient tumor are xenotransplanted in the animal 27 Avatar for drug efficacy studies and data collected in the animal trial are used 28 to plan the best drug treatment in the patient trial. Recently, zebrafish has 29 been proposed for implementing Avatar models but the lack of a general 30 criterion for chemotherapy dose conversion from humans to fishes represents 31 a limitation for conducting co-clinical trials.
INTRODUCTION 7 121 mortality (R 2 >0.87; p<0.05 for any protocol tested), (Figure 1 ). For any 122 chemotherapy treatment, the dose that is lethal to 25% of the population 123 (LD25) and the concentration at which 50% of the normal phenotype is 124 inhibited (IC50) was determined (Figure 2A) . Such data were also expressed With EPC defined as human Equivalent Plasma Concentration, given by:
128
Eq.2 = 129 M being the total amount (mg) of chemotherapy administered to humans by 130 the clinicians involved in the present study, V (ml) being the mean volume of 131 human plasma (the EPC value for each regimen is given in table S2). 132 In the present study, we fixed the 75 percentiles of the box plots ( Figure 2B ) 133 as CF corresponding to the maximum tolerated doses (MTDs). Interestingly, 134 this value was similar for the 2 conditions, i.e. CF=4.1 and CF=4.6 for 135 EPC/LD25 and EPC/IC50, respectively. Consequently, the toxicity study 136 established a conversion factor 4.6 ≤ CF < ∞ as the range for the 137 determination of the equivalent dose required for running co-clinical trials with 138 an acceptable safety level for the zebrafish trial. 155 For the estimation of the equivalent dose, we conducted an in vivo efficacy 156 study based on human cancer cell lines, whose chemosensitivity has been 157 already characterized in the literature. Specifically, 2 dpf larvae were 158 xenotransplanted with DiI-stained human colorectal carcinoma cell line (HCT 159 116) or human pancreatic carcinoma cell line (MIA PaCa-2) into the yolk sac.
160
To confirm the presence of the xenograft, injected larvae were screened by 161 fluorescence microscopy 2 hours post injection (hpi). The screened larvae 162 were randomly distributed in a multiwell plate (1 embryo/well) and equally 163 divided among groups (control and chemotherapy regimens). In absence of 164 chemotherapy, the DiI-stained area shows a statistically significant increase 165 over the time (Figure 3 , control group) and the block or the inversion of this 166 tendency has been considered in the present study as a hallmark of 167 chemotherapy effect. Indeed, we tested 4 chemotherapy regimens (5-FU, 168 FOLFOX, FOLFOXIRI, FOLFIRI), which are the standard of care for the treatment of colorectal cancers, on HCT 116 cells xenotransplanted in 2 dpf 170 larvae. According to the toxicity study, we used conversion factors CF>4.6.
171
First, a CF=8 was tested but data showed a statistically significant increase of 172 the DiI-stained area at 1 dpi and 2 dpi for all the regimens, suggesting the 173 inefficacy of chemotherapy treatment at the CF used ( Figure 3A) . Therefore, 174 we tested chemotherapy protocols at a higher concentration, corresponding to 175 CF=5. Interestingly, FOLFOXIRI were found to inhibit the increase of the 176 stained area at 1 dpi and 2 dpi (p>0.05), as opposite to the control, 5-FU,
177
FOLFOX and FOLFIRI that showed a statistically significant progression 178 ( Figure 3B ). The effect of FOLFOXIRI treatment was also confirmed by 179 quantification of apoptosis in xenotransplanted (DiI-positive) cells revealing a 180 significant increase of pyknotic nuclei with respect to the control group (no 181 chemotherapy drugs) ( Figure S1A ).
182
The next step was to confirm the value of CF=5 for dose equivalence by 183 testing its efficacy on a different model, i.e. xenotransplanted larvae receiving 184 MIA PaCa-2 cell line. Indeed, we tested 4 chemotherapy regimens (GEM, 185 GEMOX, GEM-Nab, FOLFOXIRI), which are the standard of care for the 186 treatment of pancreatic cancers, on MIA PaCa-2 cells xenotransplanted in 2 187 dpf larvae. GEM and GEM-Nab-P proved to be the most efficient regimens, 188 with no statistically significant increase of the Dil-stained area at 1 dpi and 2 189 dpi, as opposite to the control, GEMOX and FOLFOXIRI ( Figure 3C ). for presence of the stained tissue and imaged at 2 hpi, 1 dpi and 2 dpi. Cell 216 engraftment was also confirmed by histological analysis performed at 2 dpi.
217
Hoechst staining documents healthy cell nuclei ( Figure S1B ) and H&E 218 staining shows the presence of cancer cells that have the typical round-shape morphology with large nuclei ( Figure S2A ). Interestingly, H&E staining 220 performed on zebrafish embryos xenotransplanted with fragments of normal 221 tissue taken from normal mucosa or pancreatic parenchyma of the surgical 222 specimen do not show any cell with typical cancer morphology but exclusively 223 cells with a typical fibroblast-like shape ( Figure S2B ). In order to perform the 224 analysis, we measured the size of the region of interest (ROI) corresponding 225 to the stained area at 2 hpi, 1 dpi and 2 dpi ( Figure 4A3 -C3). The mean size 226 of the tumor mass area measured in each time point was normalized with 227 respect to the 2 hpi time point. We found an increase of the stained area 228 versus time in all cases, which was statistically significant at 2 dpi with respect 229 to the time point 2 hpi for 5 patients of 6 (83%, Figure 5 ). According to this 230 finding, the measure of the size of the relative stained area at 2 dpi has been 231 fixed as primary measure of the study. Sporadically we also detected cancer 232 cell migration ( Figure S3 ). gastric cancer. We adapted the "Response evaluation criteria in solid tumors 260 (RECIST)" to the fish trial by defining the partial response (PR, at least a 30% 261 decrease in the relative stained area at 2 dpi / 2 hpi, taking as reference the 262 relative stained area at 2 dpi / 2 hpi of the control group) and complete 263 response (CR, at least a 90% decrease in the relative stained area at 2 dpi / 2 264 hpi, taking as reference the relative stained area at 2 dpi / 2 hpi of the control 265 group) ( Figure 6 in clinical practice has emerged. To do that, the equivalent dose conversion 314 from human to fish need to be identified.
315
In this work, we found a general dose conversion criterion based on the 316 following formula:
Where c fish (mg/ml) is the chemotherapy concentration in fish water, M is the 319 total amount (mg) of chemotherapy administered to humans, V (ml) is the 320 volume of human plasma and CF is the conversion factor that we estimated to 321 be CF=5. We estimated this value by matching data collected from the safety 322 and efficacy studies performed in zebrafish. The safety study was performed 323 on WT larvae. The efficacy study was performed on larvae xenotransplanted 324 with human cancer cell line whose response to chemotherapy has been 325 already characterized. Specifically, we found that HCT 116 responded to Figure S1B ). The survival 363 rate of the xenografted host was acceptable, at both 1 dpi (81%, n=101) and 364 at 2 dpi (68%, n=101). We also detected the capacity of cancer cell 365 extravasion and dissemination in distal tissues ( Figure S3 ). As the relative 366 area at 2 dpi/2 hpi has been fixed as primary measure of the study, we performed the efficacy tests under the assumption that a statistically 368 significant decrease of this measure with respect to control group (no 369 chemotherapy) is a hallmark of chemotherapy response. Specifically, we 370 tested chemosensitivity in 24 human tumor fragments taken from surgical 371 specimen. To this purpose, pieces of tumor tissue were microinjected in 372 zebrafish embryos to create Zebrafish Avatar and treated with chemotherapy Figure 6B ). For the 383 group of patients affected by gastric cancer (Figure 6C ), we found an 384 excellent response to FOLFIRI that can be considered an acceptable first-line 385 treatment for advanced gastric cancers (28).
386
Interestingly, the use of zebrafish Avatars allows to appreciate a different 387 response to different chemotherapy regimens on a single-patient basis 388 (Figure 7) . Further tests will be necessary to fully validate the zebrafish Avatar were incubated for 2 h at 35°C, then embryos were checked for presence of 448 tissue and incubated at 35°C in E3 supplemented with 10000 U/ml penicillin 449 and 100 μg/ml streptomycin with the presence or absence of drugs for the 450 following days in the respect of the treatment plan.
451
Anticancer drugs toxicity and treatment plan 452 Groups of 30 embryos (2 dpf) arrayed in multiwell plates were exposed to E3 453 supplemented with 10000 U/ml penicillin and 100 μg/ml streptomycin 454 unmodified (control) and modified with the chemotherapy drug at 35°C for 24h 455 added with increasing concentrations (Tables S1, S2).
456
The drugs were refreshed each day for the three days of treatment plan. 3 457 days after treatment (3 dpt) zebrafish larvae were fixed in 4% 458 paraformaldehyde in PBS at 4°C over night. After that, they were dehydrated 459 with increasing concentration of ethanol, and analyzed by stereo microscope 460 to evaluate the phenotype (normal, death, aberrant) . Nikon Eclipse E600 microscope.
480
Cryostat sections were Hoechst 33342 counterstained. Digital images of the 481 stained sections were generated using a Nikon Eclipse Ti. Pyknotic cells was 482 counted at 40 X magnification within the epifluorescence DAPI image.
483
Statistical analysis 484 We used GraphPad Prism 7 as statistical analysis software. Data analysis 485 was performed by ANOVA, followed by Bonferroni correction or Dunnett's 486 post-hoc test or t-test. Statistical significance was set to 5%.
487
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